1
|
Mitsiou E, Parlapani E, Kirla D, Patsatsi A, Floros G, Sotiriadis D, Bozikas VP. A pilot study of resilience and severity of depressive symptoms in patients with psoriasis. Hippokratia 2022; 26:131-137. [PMID: 37497528 PMCID: PMC10367950] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/28/2023]
Abstract
Background Patients with psoriasis show an increased prevalence of depressive symptoms that worsen disease outcomes. This study investigated the effect of resilience and other sociodemographic/clinical variables on depressive symptoms' severity in patients with psoriasis. Methods This study included 58 psoriasis patients consecutively enrolled during the 14 months of the study. We evaluated psoriasis severity using the Psoriasis Area and Severity Index, Body Surface Area, and Physician Global Assessment. The psychometric assessment included the Resilience Scale and the Beck Depression Inventory-II (BDI-II). We divided participants into two subgroups based on the optimal BDI-II cut-off score (Group A: BDI-II ≤17; Group B: BDI-II >17). A stepwise regression analysis explored whether the variation in the BDI-II score could be predicted by a linear combination of sociodemographic and clinical variables. Results Psoriasis patients with more severe depressive symptoms (Group B patients) showed lower resilience levels than Group A patients (p <0.001). Moreover, depressive symptoms correlated only with resilience levels (p <0.001), with a negative correlation. The stepwise regression analysis revealed that resilience explained 37.1 % of the variance in BDI-II scores, whereas resilience, gender, and comorbidity with other physical illnesses combined explained 51.3 % of the variance. Conclusion Resilience may alleviate depressive symptoms in psoriasis patients. This study underscores the importance of resilience-building interventions for these patients. HIPPOKRATIA 2022, 26 (4):131-137.
Collapse
Affiliation(s)
- E Mitsiou
- 2nd Department of Dermatology and Venereology, Psoriasis Outpatient Clinic, General Hospital "Papageorgiou", Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - E Parlapani
- 1st Department of Psychiatry, General Hospital "Papageorgiou", Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - D Kirla
- 1st Department of Psychiatry, General Hospital "Papageorgiou", Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - A Patsatsi
- 2nd Department of Dermatology and Venereology, Psoriasis Outpatient Clinic, General Hospital "Papageorgiou", Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - G Floros
- 2nd Department of Psychiatry, Psychiatric Hospital of Thessaloniki, Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - D Sotiriadis
- 2nd Department of Dermatology and Venereology, Psoriasis Outpatient Clinic, General Hospital "Papageorgiou", Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - V P Bozikas
- 2nd Department of Psychiatry, Psychiatric Hospital of Thessaloniki, Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
| |
Collapse
|
2
|
Rigopoulos D, Patsatsi A, Antoniou C, Sotiriadis D, Roussaki-Schulze A, Boubouchairopoulou N, Skiadas I, Tsekouras V, Hernandez Daly AC. Real-world treatment patterns, patient-reported outcomes, and effectiveness of flexible-dosing etanercept in patients with plaque psoriasis in Greece. Dermatol Reports 2022; 14:9265. [DOI: 10.4081/dr.2022.9265] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2021] [Accepted: 01/11/2022] [Indexed: 11/23/2022] Open
Abstract
Etanercept is approved for continuous or intermittent use and flexible dosing in plaque psoriasis (PsO). The objectives of this study were to investigate real-world treatment patterns with etanercept in Greek adults with moderate-to-severe PsO. This non-interventional multicenter study included a retrospectiveto- prospective (RP) cohort, previously treated with etanercept for ≥24 months and followed for an additional 6 months, and a biologic-naïve, prospective-only (PO) cohort, followed for 6 months after treatment initiation. Parameters assessed included Psoriasis Area and Severity Index (PASI), percentage of body surface area (BSA) affected, Dermatology Life Quality Index (DLQI), and adverse events (AEs). This study enrolled 123 patients (RP, n = 56; PO, n = 67), who mostly adhered to continuous treatment (RP, 68%; PO, 95%). The two cohorts had similar mean baseline-to-endpoint decreases in PASI (-9.5 vs -10.1) and BSA (-11.9 vs -12.3). The PO-CTP population had a mean DLQI baseline-to-endpoint score decrease of -5.8, which was statistically significant and clinically meaningful. Treatment-emergent AE rates were 58.9% (RP) versus 26.9% (PO). These real-world data suggest a similar effectiveness of continuous and intermittent etanercept treatment in Greek patients with PsO.
Collapse
|
3
|
Patsatsi A, Kyriakou A, Douma S, Kokolios M, Meltzanidou P, Lambropoulos A, Sotiriadis D. Nichtendemischer erythrodermischer Pemphigus foliaceus: Ein Fall mit verzögerter Diagnose und Response auf Rituximab. J Dtsch Dermatol Ges 2019; 17:537-539. [DOI: 10.1111/ddg.13836_g] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- Aikaterini Patsatsi
- Bullous Diseases Outpatient Clinic2nd Department of Dermatology & VenereologyAristotle University School of MedicinePapageorgiou General Hospital Thessaloniki Greece
| | - Aikaterini Kyriakou
- Bullous Diseases Outpatient Clinic2nd Department of Dermatology & VenereologyAristotle University School of MedicinePapageorgiou General Hospital Thessaloniki Greece
| | - Stella Douma
- 3rd Department of Internal MedicineAristotle University School of MedicinePapageorgiou General Hospital Thessaloniki Greece
| | - Miltiadis Kokolios
- Bullous Diseases Outpatient Clinic2nd Department of Dermatology & VenereologyAristotle University School of MedicinePapageorgiou General Hospital Thessaloniki Greece
| | - Parthena Meltzanidou
- Bullous Diseases Outpatient Clinic2nd Department of Dermatology & VenereologyAristotle University School of MedicinePapageorgiou General Hospital Thessaloniki Greece
- Laboratory of Molecular Biology1st Department of Obstetrics & GynecologyAristotle University School of MedicinePapageorgiou General Hospital Thessaloniki Greece
| | - Alexandros Lambropoulos
- Laboratory of Molecular Biology1st Department of Obstetrics & GynecologyAristotle University School of MedicinePapageorgiou General Hospital Thessaloniki Greece
| | - Dimitrios Sotiriadis
- Bullous Diseases Outpatient Clinic2nd Department of Dermatology & VenereologyAristotle University School of MedicinePapageorgiou General Hospital Thessaloniki Greece
| |
Collapse
|
4
|
Patsatsi A, Kyriakou A, Douma S, Kokolios M, Meltzanidou P, Lambropoulos A, Sotiriadis D. Non‐endemic erythrodermic pemphigus foliaceus: a case with delayed diagnosis and response to rituximab. J Dtsch Dermatol Ges 2019; 17:537-539. [DOI: 10.1111/ddg.13836] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Aikaterini Patsatsi
- Bullous Diseases Outpatient Clinic2nd Department of Dermatology & VenereologyAristotle University School of MedicinePapageorgiou General Hospital Thessaloniki Greece
| | - Aikaterini Kyriakou
- Bullous Diseases Outpatient Clinic2nd Department of Dermatology & VenereologyAristotle University School of MedicinePapageorgiou General Hospital Thessaloniki Greece
| | - Stella Douma
- 3rd Department of Internal MedicineAristotle University School of MedicinePapageorgiou General Hospital Thessaloniki Greece
| | - Miltiadis Kokolios
- Bullous Diseases Outpatient Clinic2nd Department of Dermatology & VenereologyAristotle University School of MedicinePapageorgiou General Hospital Thessaloniki Greece
| | - Parthena Meltzanidou
- Bullous Diseases Outpatient Clinic2nd Department of Dermatology & VenereologyAristotle University School of MedicinePapageorgiou General Hospital Thessaloniki Greece
- Laboratory of Molecular Biology1st Department of Obstetrics & GynecologyAristotle University School of MedicinePapageorgiou General Hospital Thessaloniki Greece
| | - Alexandros Lambropoulos
- Laboratory of Molecular Biology1st Department of Obstetrics & GynecologyAristotle University School of MedicinePapageorgiou General Hospital Thessaloniki Greece
| | - Dimitrios Sotiriadis
- Bullous Diseases Outpatient Clinic2nd Department of Dermatology & VenereologyAristotle University School of MedicinePapageorgiou General Hospital Thessaloniki Greece
| |
Collapse
|
5
|
Kyriakou A, Trigoni A, Galanis N, Sotiriadis D, Patsatsi A. Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data. Dermatol Reports 2018; 10:7859. [PMID: 30370041 PMCID: PMC6187007 DOI: 10.4081/dr.2018.7859] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2018] [Accepted: 09/19/2018] [Indexed: 12/17/2022] Open
Abstract
Hidradenitis suppurativa (HS) is a relapsing, inflammatory disease characterized by painful nodules, abscesses, sinuses track formation and scarring. HS has a great impact on patients’ quality of life and its treatment may be really challenging. Adalimumab provides a new therapeutic option for HS. Our aim was to assess the therapeutic potential of adalimumab on patients with HS based on the data from the daily clinical practice of an HS Outpatient Clinic. 19 patients with clinically evident moderate to severe HS, under adalimumab treatment for at least 24 week, participated in this observational, retrospective study. The Hidradenitis Suppurativa Physician’s Global Assessment scale, Modified Santorius scale and Dermatology Life Quality Index (DLQI) at baseline, week 4, week 12 and week 24 were retrieved from the records. Both Modified Santorius score and DLQI were significantly decreased during the weeks of evaluation (Friedman’s test; P < 0.001). The proportion of patients who achieved clinical response was 10.5% (n = 2) at week 4, 42.1% (n = 8) at week 12 and 63.2% (n = 12) at week 24. Treatment with adalimumab was linked with both clinical remission of HS and improvement of patients’ quality of life.
Collapse
Affiliation(s)
- Aikaterini Kyriakou
- Second Department of Dermatology and Venereology, Aristotle University of Thessaloniki, General Hospital "Papageorgiou"
| | - Anastasia Trigoni
- Second Department of Dermatology and Venereology, Aristotle University of Thessaloniki, General Hospital "Papageorgiou"
| | - Nikiforos Galanis
- Division of Sports Medicine, Department of Orthopedics, Medical School, Aristotle University of Thessaloniki, Greece
| | - Dimitrios Sotiriadis
- Second Department of Dermatology and Venereology, Aristotle University of Thessaloniki, General Hospital "Papageorgiou"
| | - Aikaterini Patsatsi
- Second Department of Dermatology and Venereology, Aristotle University of Thessaloniki, General Hospital "Papageorgiou"
| |
Collapse
|
6
|
Kyriakou A, Trigoni A, Sotiriadis D, Patsatsi A. Efficacy of omalizumab in severe chronic spontaneous urticaria: Real life data from a Greek tertiary center. Dermatol Ther 2018; 31:e12739. [PMID: 30194796 DOI: 10.1111/dth.12739] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2018] [Revised: 08/16/2018] [Accepted: 09/02/2018] [Indexed: 11/30/2022]
Affiliation(s)
- A Kyriakou
- 2nd Department of Dermatology and Venereology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - A Trigoni
- 2nd Department of Dermatology and Venereology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - D Sotiriadis
- 2nd Department of Dermatology and Venereology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - A Patsatsi
- 2nd Department of Dermatology and Venereology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece
| |
Collapse
|
7
|
Kyriakou A, Patsatsi A, Sotiriadis D, Goulis DG. Effects of treatment for psoriasis on circulating levels of leptin, adiponectin and resistin: a systematic review and meta-analysis. Br J Dermatol 2018; 179:273-281. [PMID: 29432655 DOI: 10.1111/bjd.16437] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/04/2018] [Indexed: 12/14/2022]
Abstract
BACKGROUND Metabolic syndrome, a risk factor of cardiovascular disease, is more common in patients with psoriasis than in the general population. Circulating adipokine concentrations are altered in patients with psoriasis and are suggested to represent the pathophysiological link between psoriatic lesions and metabolic alterations. OBJECTIVES To perform a systematic review of the literature for studies that investigated possible differences in circulating levels of leptin, adiponectin or resistin in patients with psoriasis before and after any treatment intervention, and to meta-analyse the best evidence available. METHODS A search was conducted in three databases (PubMed, Central and Embase). Eligible for the review were studies that assessed leptin, adiponectin or resistin concentrations in patients with psoriasis before and after any topical or systemic treatment. RESULTS After treatment, blood concentrations of leptin were similar to those before treatment [standardized mean difference (SMD) 0·06, 95% confidence interval (CI) -0·09 to 0·20], with no heterogeneity among studies (I2 = 0%, P = 0·88). After treatment, blood concentrations of adiponectin were similar to those before treatment (SMD -0·14, 95% CI -0·34 to 0·05), with significant heterogeneity among studies (I2 = 36·8%, P = 0·032). After treatment, blood concentrations of resistin were significantly lower than those before treatment (SMD 0·50, 95% CI 0·20-0·79), with significant heterogeneity among studies (I2 = 61·4%, P < 0·001). CONCLUSIONS There is no evidence that treatment for psoriasis modifies leptin and adiponectin concentrations. However, treatment intervention reduces resistin concentrations, a finding that is expected to be of clinical importance.
Collapse
Affiliation(s)
- A Kyriakou
- 2nd Department of Dermatology and Venereology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - A Patsatsi
- 2nd Department of Dermatology and Venereology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - D Sotiriadis
- 2nd Department of Dermatology and Venereology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - D G Goulis
- Unit of Reproductive Endocrinology, 1st Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece
| |
Collapse
|
8
|
Petridis A, Panagakis P, Moustou E, Vergou T, Kallidis P, Mandekou-Lefaki I, Chaidemenos G, Sotiriadis D, Alexopoulou G, Haratsis Y, Antoniou C. A multicenter, prospective, observational study examining the impact of risk factors, such as BMI and waist circumference, on quality of life improvement and clinical response in moderate-to-severe plaque-type psoriasis patients treated with infliximab in. J Eur Acad Dermatol Venereol 2018; 32:768-775. [DOI: 10.1111/jdv.14802] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2017] [Accepted: 01/03/2018] [Indexed: 11/29/2022]
Affiliation(s)
- A. Petridis
- State Dermatology Clinic; A. Syggros Hospital of Venereal and Skin Diseases; Athens Greece
| | - P. Panagakis
- State Dermatology Clinic; A. Syggros Hospital of Venereal and Skin Diseases; Athens Greece
| | - E. Moustou
- 1st Department of Dermatology; A. Syggros Hospital; University of Athens; Athens Greece
| | - T. Vergou
- 1st Department of Dermatology; A. Syggros Hospital; University of Athens; Athens Greece
| | - P. Kallidis
- General Hospital of Giannitsa; Giannitsa Greece
| | - I. Mandekou-Lefaki
- State Dermatology Clinic; Hospital of Skin and Venereal Diseases of Thessaloniki; Thessaloniki Greece
| | | | - D. Sotiriadis
- Department of Dermatology; General Hospital of Thessaloniki Papageorgiou; Thessaloniki Greece
| | | | | | - C. Antoniou
- 1st Department of Dermatology; A. Syggros Hospital; University of Athens; Athens Greece
| |
Collapse
|
9
|
Kyriakou A, Patsatsi A, Sotiriadis D, Goulis DG. Serum Leptin, Resistin, and Adiponectin Concentrations in Psoriasis: A Meta-Analysis of Observational Studies. Dermatology 2017; 233:378-389. [PMID: 29232663 DOI: 10.1159/000481882] [Citation(s) in RCA: 62] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2017] [Accepted: 09/24/2017] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND Psoriasis is an immune-mediated, inflammatory disease. Adipokines contribute to the regulation of immune-mediated processes and inflammation. OBJECTIVE The aim of our study was to systematically review the literature for studies that have evaluated the circulating concentrations of adipokines in patients with psoriasis and controls and to meta-analyze the best evidence available. METHODS Eligible were studies that have assessed leptin, resistin, or adiponectin concentrations in psoriatic patients and a reference group. The study was conducted in adherence with the PRISMA standards. RESULTS Psoriatic patients had higher leptin concentrations compared to controls (random effects model, mean difference, MD = 5.64 ng/mL, 95% CI: 3.00-8.29, p < 0.0001). Heterogeneity among studies was high (I2 = 95.9%). Psoriatic patients had higher resistin concentrations compared to controls (MD = 4.66 ng/mL, 95% CI: 2.62-6.69, p < 0.0001). Heterogeneity was high (I2 = 99.2%). Finally, psoriatic patients had lower adiponectin concentrations compared to controls (MD = -1.87 μg/mL, 95% CI: -2.76 to -0.98, p < 0.0001). Heterogeneity was high (I2 = 95.9%). CONCLUSION The study supported the hypothesis that leptin and resistin concentrations are higher and adiponectin concentrations are lower in patients with psoriasis compared to controls. Hereby, the suggested pathogenic link between psoriasis and metabolic syndrome/obesity is reinforced and the role of comorbidities in psoriasis is highlighted.
Collapse
Affiliation(s)
- Aikaterini Kyriakou
- 2nd Department of Dermatology and Venereology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | | | | | | |
Collapse
|
10
|
Kokolios M, Lamprou F, Stylianidou D, Sotiriadis D, Patsatsi A. New onset pemphigus foliaceus during pregnancy: A rare case. Int J Womens Dermatol 2017; 4:109-112. [PMID: 29872686 PMCID: PMC5986257 DOI: 10.1016/j.ijwd.2017.10.010] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2017] [Revised: 10/18/2017] [Accepted: 10/19/2017] [Indexed: 12/27/2022] Open
Abstract
Pemphigus is a rare autoimmune disease during pregnancy. Among the different pemphigus types, pemphigus foliaceus (PF) is even rarer than pemphigus vulgaris. We present a case of PF in a 36-year-old female patient who presented with PF onset during pregnancy in the form of a disseminated, erythematosquamous rash. A diagnosis was made on the basis of histologic, immunofluorescence, and enzyme-linked immunosorbent assay results. A complete remission was recorded a month after steroid treatment initiation. The patient delivered a premature (33 weeks) but otherwise healthy baby girl. Only three cases of PF have been reported in two retrospective studies found in the English-language bibliography. Although pemphigus during pregnancy is a rare disease and treatment guidelines have not yet been elucidated, the management of these cases is individually evaluated. In all cases, the primary goal should be the control of the maternal disease along with the safety of the fetus.
Collapse
Affiliation(s)
- M Kokolios
- Second Department of Dermatology, Aristotle University School of Medicine, Papageorgiou General Hospital, Thessaloniki, Greece
| | - F Lamprou
- Second Department of Dermatology, Aristotle University School of Medicine, Papageorgiou General Hospital, Thessaloniki, Greece
| | - D Stylianidou
- Second Department of Dermatology, Aristotle University School of Medicine, Papageorgiou General Hospital, Thessaloniki, Greece
| | - D Sotiriadis
- Second Department of Dermatology, Aristotle University School of Medicine, Papageorgiou General Hospital, Thessaloniki, Greece
| | - A Patsatsi
- Second Department of Dermatology, Aristotle University School of Medicine, Papageorgiou General Hospital, Thessaloniki, Greece
| |
Collapse
|
11
|
Nikolis A, Fauverghe S, Scapagnini G, Sotiriadis D, Kontochristopoulos G, Petridis A, Rigopoulos D, Dessinioti C, Kalokasidis K, Antoniou C. An extension of a multicenter, randomized, split-face clinical trial evaluating the efficacy and safety of chromophore gel-assisted blue light phototherapy for the treatment of acne. Int J Dermatol 2017; 57:94-103. [DOI: 10.1111/ijd.13814] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/21/2016] [Revised: 08/17/2017] [Accepted: 09/21/2017] [Indexed: 12/31/2022]
Affiliation(s)
- Andreas Nikolis
- Division of Plastic Surgery; University of Montreal; Montreal Québec Canada
| | | | - Giovanni Scapagnini
- Department of Medicine and Health Sciences; School of Medicine; University of Molise; Campobasso Italy
| | - Dimitrios Sotiriadis
- Department of Dermatology; Aristotle University of Thessaloniki Medical School; Papageorgiou General Hospital; Thessaloniki Greece
| | | | | | - Dimitrios Rigopoulos
- Attikon University General Hospital of Athens; University of Athens; Athens Greece
| | - Clio Dessinioti
- 1st Department of Dermatology; Andreas Syggros Hospital; University of Athens; Athens Greece
| | - Konstantinos Kalokasidis
- Department of Dermatology; Aristotle University of Thessaloniki Medical School; Papageorgiou General Hospital; Thessaloniki Greece
| | - Christina Antoniou
- 1st Department of Dermatology; Andreas Syggros Hospital; University of Athens; Athens Greece
| |
Collapse
|
12
|
Patsatsi A, Kokolios M, Kyriakou A, Lamprou F, Stylianidou D, Tsapas A, Goulis DG, Murrell DF, Sotiriadis D. Quality of Life in Greek Patients with Autoimmune Bullous Diseases Assessed with ABQOL and TABQOL Indexes. Acta Derm Venereol 2017; 97:1145-1147. [PMID: 28660281 DOI: 10.2340/00015555-2737] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
is missing (Short communication).
Collapse
Affiliation(s)
- Aikaterini Patsatsi
- 2nd Dermatology Department, Medical School, Aristotle University of Thessaloniki, Papageorgiou General Hospital, GR-56403 Thessaloniki,, Greece. ,
| | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Patsatsi A, Lamprou F, Kokolios M, Stylianidou D, Trigoni A, Kalampalikis D, Sotiriadis D. Spectrum of Autoimmune Bullous Diseases in Northern Greece. A 4-year Retrospective Study and Review of the Literature. Acta Dermatovenerol Croat 2017; 25:195-201. [PMID: 29252171] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
Bullous Diseases Unit at the 2nd Department of Dermatology and Venereology, Aristotle University of Thessaloniki was founded with the aim to provide the optimal diagnostic approach and treatment of patients with autoimmune bullous diseases (AΙBD). We processed all AIBD files of patients diagnosed from 2011 to 2014 in order to record all epidemiological data and therapeutic manipulations during monitoring. 57 patients were diagnosed with intraepidermal and 62 with subepidermal bullous diseases. There were 51 cases (89%) of pemphigus vulgaris (PV) and 6 (11%) of pemphigus foliaceus (PF), whereas 45 (73%) patients were diagnosed with bullous pemphigoid (BP), 9 (14%) with mucous membrane pemphigoid (MMP), 3 (5%) with pemphigoid gestationis (PG), 3 (5%) with linear IgA dermatosis (LAD), 1 (2%) with epidermolysis bullosa aquisita (EBA), and 1 patient with an undefined subepidermal AIBD. The mean age of patients within the pemphigus spectrum was 57 years. In the pemphigoid spectrum, the mean age was 72 years. Comorbidities were reported with increasing frequency, as well as treatment options other than systemic corticosteroids, such as adjuvant immunosuppressive agents, which were used to achieve complete remission. This is a report from a tertiary AIBD Referral Center in northern Greece. Our data from a 4-year period contribute to the completion of the global geographic incidence map of AIBD.
Collapse
Affiliation(s)
| | - Foteini Lamprou
- Foteini Lamprou, MD, MSc, PhD candidate, 2nd University Department of Dermatology Papageorgiou General Hospital Aristotle University of Thessaloniki, Ring Road, Municipality of Pavlos Melas, Area of N. Efkarpia, 56403 Thessaloniki, Greece;
| | | | | | | | | | | |
Collapse
|
14
|
Tsentemeidou A, Vyzantiadis TA, Kyriakou A, Sotiriadis D, Patsatsi A. Prevalence of onychomycosis among patients with nail psoriasis who are not receiving immunosuppressive agents: Results of a pilot study. Mycoses 2017; 60:830-835. [DOI: 10.1111/myc.12681] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2017] [Revised: 08/02/2017] [Accepted: 08/12/2017] [Indexed: 01/19/2023]
Affiliation(s)
- Aikaterini Tsentemeidou
- 2nd Department of Dermatology; Faculty of Medicine; Aristotle University; Papageorgiou General Hospital; Thessaloniki Greece
| | | | - Aikaterini Kyriakou
- 2nd Department of Dermatology; Faculty of Medicine; Aristotle University; Papageorgiou General Hospital; Thessaloniki Greece
| | - Dimitrios Sotiriadis
- 2nd Department of Dermatology; Faculty of Medicine; Aristotle University; Papageorgiou General Hospital; Thessaloniki Greece
| | - Aikaterini Patsatsi
- 2nd Department of Dermatology; Faculty of Medicine; Aristotle University; Papageorgiou General Hospital; Thessaloniki Greece
| |
Collapse
|
15
|
Patsatsi A, Meltzanidou P, Katafigiotis S, Sotiriadis D, Schmidt E, Lambropoulos A. Chronic bullous disease of childhood with IgG reactivity to p200 antigen. Int J Dermatol 2017; 56:773-775. [DOI: 10.1111/ijd.13616] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/30/2016] [Revised: 12/28/2016] [Accepted: 03/10/2017] [Indexed: 11/26/2022]
Affiliation(s)
- Aikaterini Patsatsi
- 2nd University Dermatology Department; Aristotle University School of Medicine; Papageorgiou General Hospital; Thessaloniki Greece
| | - Parthena Meltzanidou
- Molecular Biology Laboratory; 1st Department of Obstetrics and Gynecology; Aristotle University School of Medicine; Papageorgiou General Hospital; Thessaloniki Greece
| | - Socrates Katafigiotis
- Molecular Biology Laboratory; 1st Department of Obstetrics and Gynecology; Aristotle University School of Medicine; Papageorgiou General Hospital; Thessaloniki Greece
| | - Dimitrios Sotiriadis
- 2nd University Dermatology Department; Aristotle University School of Medicine; Papageorgiou General Hospital; Thessaloniki Greece
| | - Enno Schmidt
- Department of Dermatology; University of Luebeck; Luebeck Germany
| | - Alexandros Lambropoulos
- Molecular Biology Laboratory; 1st Department of Obstetrics and Gynecology; Aristotle University School of Medicine; Papageorgiou General Hospital; Thessaloniki Greece
| |
Collapse
|
16
|
Hwatar R, Sotiriadis D, Rhone J, Sideris G, Mirpour S, Ivkov R, Liapi E. Validation of quantification of liver tumor CT perfusion values with intra-arterial injection of stable labeled microspheres. J Vasc Interv Radiol 2017. [DOI: 10.1016/j.jvir.2016.12.1077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
17
|
Sarri CA, Roussaki-Schulze A, Vasilopoulos Y, Zafiriou E, Patsatsi A, Stamatis C, Gidarokosta P, Sotiriadis D, Sarafidou T, Mamuris Z. Netherton Syndrome: A Genotype-Phenotype Review. Mol Diagn Ther 2016; 21:137-152. [DOI: 10.1007/s40291-016-0243-y] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
18
|
Kotrotsiou T, Chatzimichaloglou A, Nasr A, Spandou E, Patsatsi A, Sotiriadis D, Vyzantiadis TA. A comparative study of three extraction protocols of DNA from nails: Potential use in the diagnosis of onychomycoses. Mycoses 2016; 60:183-187. [DOI: 10.1111/myc.12581] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2016] [Revised: 10/06/2016] [Accepted: 10/08/2016] [Indexed: 11/27/2022]
Affiliation(s)
- T. Kotrotsiou
- 1st Department of Microbiology; Medical School; Aristotle University of Thessaloniki; Thessaloniki Greece
| | - A. Chatzimichaloglou
- 1st Department of Microbiology; Medical School; Aristotle University of Thessaloniki; Thessaloniki Greece
| | - A. Nasr
- 2nd Department of Dermatology; Medical School; Aristotle University of Thessaloniki; Thessaloniki Greece
| | - E. Spandou
- Department of Experimental Physiology; Medical School; Aristotle University of Thessaloniki; Greece
| | - A. Patsatsi
- 2nd Department of Dermatology; Medical School; Aristotle University of Thessaloniki; Thessaloniki Greece
| | - D. Sotiriadis
- 2nd Department of Dermatology; Medical School; Aristotle University of Thessaloniki; Thessaloniki Greece
| | - T.-A. Vyzantiadis
- 1st Department of Microbiology; Medical School; Aristotle University of Thessaloniki; Thessaloniki Greece
| |
Collapse
|
19
|
Abstract
Regression of congenital nevi is usually associated with loss of pigment or halo formation. In rare cases, regression is characterized by sclerosis and hair loss. We describe a rare case of a sclerotic hypopigmented large congenital melanocytic nevus in which a localized scleroderma-like reaction process of regression seemed to have started in utero and progressed throughout early childhood.
Collapse
Affiliation(s)
- Aikaterini Patsatsi
- Second Department of Dermatology, Faculty of Medicine, Aristotle University, Papageorgiou General Hospital, Thessaloniki, Greece
| | - Miltiadis Kokolios
- Second Department of Dermatology, Faculty of Medicine, Aristotle University, Papageorgiou General Hospital, Thessaloniki, Greece
| | - Olga Pikou
- Second Department of Dermatology, Faculty of Medicine, Aristotle University, Papageorgiou General Hospital, Thessaloniki, Greece
| | - Vasilios Lambropoulos
- Department of Pediatric Surgery, Faculty of Medicine, Aristotle University, Papageorgiou General Hospital, Thessaloniki, Greece
| | - Ioannis Efstratiou
- Department of Pathology, Papageorgiou General Hospital, Thessaloniki, Greece
| | - Dimitrios Sotiriadis
- Second Department of Dermatology, Faculty of Medicine, Aristotle University, Papageorgiou General Hospital, Thessaloniki, Greece
| |
Collapse
|
20
|
Antoniou C, Dessinioti C, Sotiriadis D, Kalokasidis K, Kontochristopoulos G, Petridis A, Rigopoulos D, Vezina D, Nikolis A. A multicenter, randomized, split-face clinical trial evaluating the efficacy and safety of chromophore gel-assisted blue light phototherapy for the treatment of acne. Int J Dermatol 2016; 55:1321-1328. [DOI: 10.1111/ijd.13349] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/06/2015] [Revised: 02/28/2016] [Accepted: 03/20/2016] [Indexed: 12/31/2022]
Affiliation(s)
- Christina Antoniou
- 1st Department of Dermatology; University of Athens; Andreas Sygros Hospital; Athens Greece
| | - Clio Dessinioti
- 1st Department of Dermatology; University of Athens; Andreas Sygros Hospital; Athens Greece
| | - Dimitrios Sotiriadis
- Department of Dermatology; Aristotle University of Thessaloniki Medical School; Papageorgiou General Hospital; Thessaloniki Greece
| | - Konstantinos Kalokasidis
- Department of Dermatology; Aristotle University of Thessaloniki Medical School; Papageorgiou General Hospital; Thessaloniki Greece
| | | | | | - Dimitrios Rigopoulos
- University of Athens; Attikon University General Hospital of Athens; Athens Greece
| | | | - Andreas Nikolis
- Division of Plastic Surgery; University of Montreal; Montreal Canada
- Victoria Park Research Centre; Plastic Surgery Section; Montreal Canada
| |
Collapse
|
21
|
Nasr A, Vyzantiadis T, Patsatsi A, Louka A, Ioakimidou A, Zachrou E, Chavale A, Kalabalikis D, Malissiovas N, Sotiriadis D. Epidemiology of superficial mycoses in Northern Greece: a 4-year study. J Eur Acad Dermatol Venereol 2015; 30:837-9. [DOI: 10.1111/jdv.13121] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2014] [Accepted: 03/02/2015] [Indexed: 11/28/2022]
Affiliation(s)
- A. Nasr
- 2nd Dermatology Department; Medical School; Aristotle University of Thessaloniki; Thessaloniki Greece
| | - T.A. Vyzantiadis
- 1st Department of Microbiology; Medical School; Aristotle University of Thessaloniki; Thessaloniki Greece
| | - A. Patsatsi
- 2nd Dermatology Department; Medical School; Aristotle University of Thessaloniki; Thessaloniki Greece
| | - A. Louka
- 1st Department of Microbiology; Medical School; Aristotle University of Thessaloniki; Thessaloniki Greece
| | - A. Ioakimidou
- 1st Department of Microbiology; Medical School; Aristotle University of Thessaloniki; Thessaloniki Greece
| | - E. Zachrou
- 1st Department of Microbiology; Medical School; Aristotle University of Thessaloniki; Thessaloniki Greece
| | - A. Chavale
- 1st Department of Microbiology; Medical School; Aristotle University of Thessaloniki; Thessaloniki Greece
| | - D. Kalabalikis
- 2nd Dermatology Department; Medical School; Aristotle University of Thessaloniki; Thessaloniki Greece
| | - N. Malissiovas
- 1st Department of Microbiology; Medical School; Aristotle University of Thessaloniki; Thessaloniki Greece
| | - D. Sotiriadis
- 2nd Dermatology Department; Medical School; Aristotle University of Thessaloniki; Thessaloniki Greece
| |
Collapse
|
22
|
Kyriakou A, Patsatsi A, Sotiriadis D. Die Übereinstimmung verschiedener Messmethoden des Nail Psoriasis Severity Index (NAPSI) und deren Korrelation mit dem Dermatology Life Quality Index (DLQI). J Dtsch Dermatol Ges 2014. [DOI: 10.1111/ddg.12432_suppl] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Aikaterini Kyriakou
- Second Department of Dermatology and Venereology; Aristotle University School of Medicine; Thessaloniki Griechenland
| | - Aikaterini Patsatsi
- Second Department of Dermatology and Venereology; Aristotle University School of Medicine; Thessaloniki Griechenland
| | - Dimitrios Sotiriadis
- Second Department of Dermatology and Venereology; Aristotle University School of Medicine; Thessaloniki Griechenland
| |
Collapse
|
23
|
Patsatsi A, Kyriakou A, Mantas A, Vavilis D, Patsialas C, Sotiriadis D. Circulating anti-BP180 NC16a and anti-BP230 autoantibodies in patients with genital lichen sclerosus do not correlate with disease activity and pruritus. Acta Derm Venereol 2014; 94:711-2. [PMID: 24676719 DOI: 10.2340/00015555-1851] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Affiliation(s)
- Aikaterini Patsatsi
- 2nd Dermatology Department, Aristotle University School of Medicine, GR-57500 Thessaloniki,, Greece
| | | | | | | | | | | |
Collapse
|
24
|
Kyriakou A, Patsatsi A, Sotiriadis D. The agreement among the different ways of measuring NAPSI and their correlation with DLQI. J Dtsch Dermatol Ges 2014; 12:1051-3. [PMID: 25263182 DOI: 10.1111/ddg.12432] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Aikaterini Kyriakou
- Second Department of Dermatology and Venereology, Aristotle University School of Medicine, Thessaloniki, Greece
| | | | | |
Collapse
|
25
|
Abstract
Benign cephalic histiocytosis (BCH) is a rare type of non-Langerhans histiocytic disorder, usually presenting with small, yellow-red or yellow-brown, asymptomatic papules, located mostly on the head and neck of infants and young children. The histopathologic hallmark of BCH is a well-circumscribed histiocytic infiltrate in the superficial to mid-reticular dermis. BCH is a self-healing disorder, with the eruptions regressing spontaneously in most cases; therefore no treatment is required. We present a case of BCH in a 7-month-old boy who was referred to our department with multiple, asymptomatic, yellow-red papules located on his face, and we review 55 cases published in the English-language literature in an effort to better describe and understand this unusual entity.
Collapse
Affiliation(s)
- Aikaterini Patsatsi
- Second Dermatology Department, Aristotle University School of Medicine, Thessaloniki, Greece
| | | | | |
Collapse
|
26
|
Spyropoulou G, Pavlidis L, Trakatelli M, Athanasiou E, Pazarli E, Sotiriadis D, Demiri E. Rare benign tumours of the nipple. J Eur Acad Dermatol Venereol 2014; 29:7-13. [DOI: 10.1111/jdv.12623] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2014] [Accepted: 06/05/2014] [Indexed: 11/29/2022]
Affiliation(s)
- G.A. Spyropoulou
- Department of Plastic and Reconstructive Surgery; Aristotle University of Thessaloniki; Papageorgiou General Hospital; Thessaloniki Greece
| | - L. Pavlidis
- Department of Plastic and Reconstructive Surgery; Aristotle University of Thessaloniki; Papageorgiou General Hospital; Thessaloniki Greece
| | - M. Trakatelli
- Department of Dermatology; Aristotle University of Thessaloniki; Papageorgiou General Hospital; Thessaloniki Greece
| | - E. Athanasiou
- Department of molecular and gene therapy; Hematology Clinic; Papanikolaou General Hospital; Thessaloniki Greece
| | - E. Pazarli
- Department of Pathology; Papageorgiou General Hospital; Thessaloniki Greece
| | - D. Sotiriadis
- Department of Dermatology; Aristotle University of Thessaloniki; Papageorgiou General Hospital; Thessaloniki Greece
| | - E. Demiri
- Department of Plastic and Reconstructive Surgery; Aristotle University of Thessaloniki; Papageorgiou General Hospital; Thessaloniki Greece
| |
Collapse
|
27
|
Patsatsi A, Kyriakou A, Nasr A, Efstratiou I, Sotiriadis D. Disseminated waxy papules: a sign of systemic disease. Cutis 2014; 94:E3-E4. [PMID: 25101352] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
|
28
|
Talaganis JA, Biello K, Plaka M, Polydorou D, Papadopoulos O, Trakatelli M, Sotiriadis D, Tsoutsos D, Kechagias G, Gogas H, Antoniou C, Swetter SM, Geller AC, Stratigos AJ. Demographic, behavioural and physician-related determinants of early melanoma detection in a low-incidence population. Br J Dermatol 2014; 171:832-8. [PMID: 24749902 DOI: 10.1111/bjd.13068] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/17/2014] [Indexed: 12/12/2022]
Abstract
BACKGROUND Knowledge of the factors that influence early detection of melanoma is important in developing strategies to reduce associated mortality. OBJECTIVES To identify sociodemographic, behavioural and medical care-related factors associated with melanoma thickness in a low-incidence population but with a high case fatality. PATIENTS AND METHODS In a multicentre, retrospective, survey-based study of 202 patients with a recent diagnosis of invasive melanoma (< 1 year), we collected data on demographic and behavioural factors, attitudes towards prevention, access to medical care, frequency of skin self-examination (SSE) and physician skin examination (PSE) in relation to melanoma thickness. RESULTS Thinner tumours (≤ 1 mm, 80 melanomas) were associated with female sex (P ≤ 0.049), nonnodular (superficial spreading melanoma, lentigo maligna melanoma, acral lentiginous melanoma) histological subtypes (P < 0.001), absence of ulceration (P ≤ 0.001), and location other than lower extremity or trunk location (P ≤ 0.004). Patients married at the time of diagnosis or who performed SSE during the year prior to diagnosis were more likely to have thinner tumours than those who did not [odds ratio (OR) 3.45, 95% confidence interval (CI) 1.48-8.04 and OR 2.43, 95% CI 1.10-5.34, respectively]. Full-body skin examination by a physician was not significantly associated with thinner melanoma (OR 1.99, 95% CI 0.66-6.07). CONCLUSIONS SSE was shown to be an important factor in the detection of thin melanoma, in contrast to partial or full-body PSE, which did not show any statistically significant effect on tumour thickness.
Collapse
Affiliation(s)
- J A Talaganis
- Department of Dermatology, University of Athens Medical School, Andreas Sygros Hospital, Dragoumi 5, 161 21, Athens, Greece
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
29
|
Patsatsi A, Koletsa T, Sotiriadis D, Batsis I, Sakellari I, Anagnostopoulos A, Papadaki T, Kostopoulos I. Silent T-cell lymphoma of γδ T-cell origin initially presented as panniculitis. J Eur Acad Dermatol Venereol 2014; 29:1244-5. [PMID: 24641297 DOI: 10.1111/jdv.12477] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Affiliation(s)
- A Patsatsi
- 2nd Department of Dermatology, Aristotle University School of Medicine, Thessaloniki, Greece
| | - T Koletsa
- Department of Pathology, Aristotle University School of Medicine, Thessaloniki, Greece
| | - D Sotiriadis
- 2nd Department of Dermatology, Aristotle University School of Medicine, Thessaloniki, Greece
| | - I Batsis
- Department of Hematology, George Papanikolaou General Hospital, Thessaloniki, Greece
| | - I Sakellari
- Department of Hematology, George Papanikolaou General Hospital, Thessaloniki, Greece
| | - A Anagnostopoulos
- Department of Hematology, George Papanikolaou General Hospital, Thessaloniki, Greece
| | - T Papadaki
- Department of Hematopathology, Evangelismos Hospital, Athens, Greece
| | - I Kostopoulos
- Department of Pathology, Aristotle University School of Medicine, Thessaloniki, Greece
| |
Collapse
|
30
|
Patsatsi A, Kyriakou A, Giannakou A, Pavlitou-Tsiontsi A, Lambropoulos A, Sotiriadis D. Clinical significance of anti-desmoglein-1 and -3 circulating autoantibodies in Pemphigus Patients Measured by Area Index and Intensity Score. Acta Derm Venereol 2014; 94:203-6. [PMID: 23995461 DOI: 10.2340/00015555-1666] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Detection of anti-desmoglein-1 (anti-DSG-1) and anti-DSG-3 autoantibodies is widely used in the diagnosis of pemphigus. Two validated scoring systems, Pemphigus Disease Area Index (PDAI) and Autoimmune Bullous Skin Disorder Intensity Score (ABSIS), are used for the evaluation of clinical severity. The aim of this cross-sectional study was to interpret the titres of pemphigus autoantibodies in correlation with either total or location-dependent PDAI scores and ABSIS. A total of 35 pemphigus patients were selected and evaluated at 3 time points. Total PDAI and ABSIS seemed useful in pemphigus with cutaneous lesions or in the mucocutaneous form, while location-dependent PDAI and ABSIS scores were useful in the mucosal form. Anti-DSG-1 autoantibodies titres better showed the disease extent in pemphigus with cutaneous only or with mucocutaneous lesions. Anti-DSG-3 autoantibodies titres did not correlate to disease activity.
Collapse
Affiliation(s)
- Aikaterini Patsatsi
- 2nd Dermatology Department, Aristotle University School of Medicine, GR-57500 Thessaloniki,, Greece
| | | | | | | | | | | |
Collapse
|
31
|
Patsatsi A, Lazaridou E, Fotiadou C, Kyriakou A, Sotiriadis D. Large cell acanthoma: a debate throughout the decades. Dermatol Pract Concept 2014; 4:43-5. [PMID: 24520512 PMCID: PMC3919838 DOI: 10.5826/dpc.0401a05] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2013] [Accepted: 10/23/2013] [Indexed: 11/07/2022] Open
Affiliation(s)
- Aikaterini Patsatsi
- Second Department of Dermatology, Aristotle University School of Medicine, Thessaloniki, Greece
| | - Elizabeth Lazaridou
- First Department of Dermatology, Aristotle University School of Medicine, Thessaloniki, Greece
| | - Christina Fotiadou
- First Department of Dermatology, Aristotle University School of Medicine, Thessaloniki, Greece
| | - Aikaterini Kyriakou
- Second Department of Dermatology, Aristotle University School of Medicine, Thessaloniki, Greece
| | - Dimitrios Sotiriadis
- Second Department of Dermatology, Aristotle University School of Medicine, Thessaloniki, Greece
| |
Collapse
|
32
|
Patsatsi A, Kyriakou A, Karavasilis V, Tsatsou F, Lazaridis G, Kalabalikis D, Sotiriadis D. Acquired ichthyosis triggered by an osseous hemangiopericytoma: a case report and review of the literature. Case Rep Dermatol 2014; 6:10-5. [PMID: 24575005 PMCID: PMC3934780 DOI: 10.1159/000358294] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Ichthyoses are a heterogeneous group of cutaneous keratinization disorders that can be congenital or acquired. Apart from neoplastic disorders, the acquired form of ichthyosis (AI) has been associated with a variety of diseases including infections, autoimmune/inflammatory and endocrine/metabolic diseases as well as nutritional conditions, medications and others. However, malignancy accounts for half of the reported cases, most commonly including lymphoproliferative disorders. We present a case of AI as a paraneoplastic skin manifestation of a primary, osseous hemangiopericytoma (HP) accompanied by multiple liver metastases. We also review the literature and discuss the necessity of investigating underlying diseases, especially malignancy, when adult-onset ichthyosis arises.
Collapse
Affiliation(s)
- Aikaterini Patsatsi
- 2nd Department of Dermatology and Venereology, Aristotle University School of Medicine, Thessaloniki, Greece
| | - Aikaterini Kyriakou
- 2nd Department of Dermatology and Venereology, Aristotle University School of Medicine, Thessaloniki, Greece
| | - Vasilios Karavasilis
- Department of Medical Oncology, Aristotle University School of Medicine, Thessaloniki, Greece
| | - Fragkiski Tsatsou
- 2nd Department of Dermatology and Venereology, Aristotle University School of Medicine, Thessaloniki, Greece
| | - Georgios Lazaridis
- Department of Medical Oncology, Aristotle University School of Medicine, Thessaloniki, Greece
| | - Dimitrios Kalabalikis
- 2nd Department of Dermatology and Venereology, Aristotle University School of Medicine, Thessaloniki, Greece
| | - Dimitrios Sotiriadis
- 2nd Department of Dermatology and Venereology, Aristotle University School of Medicine, Thessaloniki, Greece
| |
Collapse
|
33
|
Kyriakou A, Patsatsi A, Patsialas C, Sotiriadis D. Therapeutic Efficacy of Topical Calcineurin Inhibitors in Plasma Cell Balanitis: Case Series and Review of the Literature. Dermatology 2014; 228:18-23. [DOI: 10.1159/000357153] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2013] [Accepted: 11/05/2013] [Indexed: 11/19/2022] Open
|
34
|
Ziakas A, Theofilogiannakos EK, Daniilidis M, Sotiriadis D, Parisiadou A, Kotsaftis P, Gemitzis K, Parharidis G. Clopidogrel and ticlopidine cross-reactivity-induced erythroderma following drug-eluting stenting. Cutis 2013; 92:E16-E17. [PMID: 24416752] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
|
35
|
|
36
|
Patsatsi A, Kyriakou A, Chaidemenos G, Sotiriadis D. Linear atrophoderma of Moulin: a case report and review of the literature. Dermatol Pract Concept 2013; 3:7-11. [PMID: 23785629 PMCID: PMC3663377 DOI: 10.5826/dpc.0301a03] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2012] [Accepted: 11/25/2012] [Indexed: 11/29/2022] Open
Abstract
Linear atrophoderma of Moulin is a rare, acquired, linear dermatosis. We present a 17-year-old girl with multiple asymptomatic brownish atrophic plaques in a zosteriform distribution on the left side of the trunk. Clinical presentation and dermatopathology was compatible with the diagnosis of linear atrophoderma. Twenty years after its initial description by Moulin, there are yet a limited number of case reports and unanswered questions regarding this entity.
Collapse
Affiliation(s)
- Aikaterini Patsatsi
- Second Dermatology Department, Aristotle University School of Medicine, Papageorgiou Hospital, Thessaloniki, Greece
| | | | | | | |
Collapse
|
37
|
Kyriakou A, Patsialas C, Patsatsi A, Sotiriadis D. Treatment of male genital lichen sclerosus with clobetasol propionate and maintenance with either methylprednisolone aceponate or tacrolimus: a retrospective study. J DERMATOL TREAT 2013; 24:431-4. [PMID: 23472631 DOI: 10.3109/09546634.2013.782385] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
OBJECTIVE To assess the efficacy of clobetasol propionate 0.05% cream in male patients suffering from genital lichen sclerosus (GLS), as well as the efficacy of methylprednisolone aceponate 0.1% cream and tacrolimus 0.1% ointment as maintenance therapy. METHODS The study was conducted retrospectively. At baseline, male patients with GLS (n = 41) were treated with clobetasol propionate 0.05% cream applied twice daily for 8 weeks. Visual Analog Scale (VAS) score for pruritus, Investigator's Global Assessment (IGA) score and Dermatology Life Quality Index (DLQI) were recorded at baseline, week 8 and week 20. At week 8, patients responsive to treatment (n = 37) were further treated with methylprednisolone aceponate 0.1% cream twice weekly (n = 17) or tacrolimus 0.1% ointment once daily (n = 20), as maintenance therapy until week 20. RESULTS VAS, IGA and DLQI median scores were significantly decreased from baseline to week 8 (p < 0.001). At week 20, patients treated with methylprednisolone aceponate 0.1% cream presented no significant difference in median IGA score (p = 0.865), median DLQI score (p = 0.853) or median VAS score (p = 0.474) compared with patients treated with tacrolimus 0.1% ointment. CONCLUSIONS Clobetasol propionate 0.05% cream is effective as first-line treatment in male GLS. The data suggest that there is no difference between methylprednisolone aceponate 0.1% cream and tacrolimus 0.1% ointment in preventing the relapses.
Collapse
Affiliation(s)
- Aikaterini Kyriakou
- 2nd Department of Dermatology and Venereology, Aristotle University School of Medicine , Thessaloniki , Greece
| | | | | | | |
Collapse
|
38
|
Patsatsi A, Kyriakou A, Karavasilis V, Panteliadou K, Sotiriadis D. Primary cutaneous diffuse large B-cell lymphoma, leg type, with multiple local relapses: case presentation and brief review of literature. Hippokratia 2013; 17:174-176. [PMID: 24376327 PMCID: PMC3743626] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBL-LT) is a primary cutaneous B-cell lymphoma of intermediate behavior. The disease predominantly affects elderly patients. A 76-year old man presented with red to violaceous nodules in the anterior aspect of both tibias. Histology confirmed the diagnosis of PCDLBL-LT. A thorough clinical and laboratory investigation was negative for any systemic involvement. However, computed tomography of the thorax showed mediastinal lymphadenopathy. Both bone marrow aspiration and trephine did not show any evidence of bone marrow infiltration. Initially R-CHOP regimen (rituximab-cyclophosphamide, doxorubicin, vincristine, prednisone) achieved a total clearance of the lesions. Nevertheless, five months later patient presented with a relapse and was managed with palliative radiotherapy. The same treatment modality was applied for the second recurrence, as well. PCDLBL-LT affects mostly elderly patients. The consequent age related comorbidities and the frequent relapses require a strict follow up of the patients.
Collapse
Affiliation(s)
| | | | - V Karavasilis
- Department of Medical Oncology, Medical School, Aristotle University, Papageorgiou Hospital, Thessaloniki, Greece
| | | | | |
Collapse
|
39
|
Patsatsi A, Theodoridis TD, Vavilis D, Tzevelekis V, Kyriakou A, Kalabalikis D, Sotiriadis D. Cyclosporine in the management of impetigo herpetiformis: a case report and review of the literature. Case Rep Dermatol 2013; 5:99-104. [PMID: 23626548 PMCID: PMC3635965 DOI: 10.1159/000350564] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
A 27-year-old female, gravida 1, para 0, in week 22 of pregnancy, presented with an eruption consisting of annular erythematosquamous plaques with an active polycyclic elevated border comprised of superficial micropustules. Clinical and histological features were typical of impetigo herpetiformis (IH). Systemic steroids resulted in an unstable condition, with no resolution of lesions. Resistance to the above therapeutic scheme served as a stimulus to discuss the use of cyclosporine as a therapeutic option in this condition. Reviewing the limited literature, cyclosporine seems to serve not as a monotherapy in the management of IH but as an additional medication, in order to achieve a stable course of the disease and avoid high doses of systemic steroids.
Collapse
Affiliation(s)
- Aikaterini Patsatsi
- 2nd Department of Dermatology and Venereology, Aristotle University School of Medicine, Papageorgiou Hospital, Thessaloniki, Greece
| | | | | | | | | | | | | |
Collapse
|
40
|
Koletsa T, Patsatsi A, Kostopoulos I, Georgiou E, Sotiriadis D. Beteiligung der Ohrläppchen bei chronischer lymphatischer Leukämie. J Dtsch Dermatol Ges 2013. [DOI: 10.1111/j.1610-0387.2012.08054_suppl.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
41
|
|
42
|
Patsatsi A, Kyriakou A, Pavlitou-Tsiontsi A, Giannakou A, Sotiriadis D. Association of autoantibodies to BP180 with disease activity in Greek patients with bullous pemphigoid. Clin Dev Immunol 2012; 2012:854795. [PMID: 23227089 PMCID: PMC3514843 DOI: 10.1155/2012/854795] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2012] [Revised: 10/24/2012] [Accepted: 10/25/2012] [Indexed: 11/17/2022]
Abstract
39 bullous pemphigoid (BP) patients were studied to assess the clinical significance of anti-BP180 and anti-BP230 circulating autoantibodies of BP and correlate their titers with the clinical scores of the BP Disease Area Index (BPDAI) and the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) as well as with the intensity of pruritus measured by the BPDAI pruritus component. All parameters were evaluated by the time of diagnosis (baseline), month 3, and month 6. Titers of anti-BP180 autoantibodies were strongly correlated with BPDAI (r = 0.557, P value < 0.0001) and ABSIS (r = 0.570, P value < 0.0001) values, as well as with BPDAI component for the intensity of pruritus (rho = 0.530, P value = 0.001) at baseline. At month 3, titers of anti-BP180 autoantibodies were strongly correlated with BPDAI (rho = 0.626, P value = 0.000) and ABSIS (rho = 0.625, P value = 0.000) values, as well as with the BPDAI component for the intensity of pruritus (rho = 0.625, P value = 0.000). At month 6, titers of anti-BP180 autoantibodies were strongly correlated with BPDAI (rho = 0.527, P value = 0.001) and ABSIS (rho = 0.526, P value = 0.001) values, as well as with the BPDAI component for the intensity of pruritus (rho = 0.525, P value = 0.001). There was no statistically significant correlation between titers of anti-BP230 autoantibodies and the BPDAI, ABSIS, and BPDAI component for the intensity of pruritus at the same time points.
Collapse
Affiliation(s)
- Aikaterini Patsatsi
- 2nd Department of Dermatology and Venereology, Papageorgiou General Hospital, Aristotle University School of Medicine, Nea Eflkarpia, Ring Road Thessalonikis, 56403 Thessaloniki, Greece
| | - Aikaterini Kyriakou
- 2nd Department of Dermatology and Venereology, Papageorgiou General Hospital, Aristotle University School of Medicine, Nea Eflkarpia, Ring Road Thessalonikis, 56403 Thessaloniki, Greece
| | - Aikaterini Pavlitou-Tsiontsi
- Immunology Laboratory, Papageorgiou General Hospital, Nea Eflkarpia, Ring Road Thessalonikis, 56403 Thessaloniki, Greece
| | - Anastasia Giannakou
- Immunology Laboratory, Papageorgiou General Hospital, Nea Eflkarpia, Ring Road Thessalonikis, 56403 Thessaloniki, Greece
| | - Dimitrios Sotiriadis
- 2nd Department of Dermatology and Venereology, Papageorgiou General Hospital, Aristotle University School of Medicine, Nea Eflkarpia, Ring Road Thessalonikis, 56403 Thessaloniki, Greece
| |
Collapse
|
43
|
Patsatsi A, Kyriakou A, Vavilis D, Mantas A, Patsialas C, Sotiriadis D. A therapeutic approach for female, relapsing genital lichen sclerosus: a single-center study. J DERMATOL TREAT 2012; 24:336-9. [PMID: 23164046 DOI: 10.3109/09546634.2012.751086] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
OBJECTIVE To assess the efficacy of methylprednisolone aceponate 0.1% (MPA 0.1%) in female genital lichen sclerosus (GLS) and efficacy of MPA, tacrolimus or emollient for prevention of flares. METHODS A single-center, retrospective study was conducted. At baseline, female patients with relapsing GLS (n = 46) were treated with MPA 0.1% applied once daily for 8 weeks. Visual Analog Scale (VAS) score for vulvar pruritus and Investigator's Global Assessment (IGA) score were recorded at baseline, weeks 8 and 20. At week 8, patients responsive to treatment (n = 38) were further treated with MPA 0.1% twice weekly (n = 15), tacrolimus once daily (n = 13) or topical emollient once daily (n = 10), as maintenance therapy until week 20. RESULT Both VAS and IGA median score was significantly decreased from baseline to week 8 (p = 0.000). At week 20, both median VAS and IGA scores differed significantly between patients treated with emollient and patients treated with MPA 0.1% (p = 0.000) and patients treated with emollient and patients treated with tacrolimus (p = 0.000); patients treated with MPA 0.1% presented no significant difference in either median VAS score (p = 0.032) or median IGA score (p = 0.636) at week 20 compared to patients treated with tacrolimus. CONCLUSIONS MPA 0.1% is effective in relapsing female GLS. MPA 0.1% and tacrolimus have equal efficacy in preventing relapses.
Collapse
Affiliation(s)
- Aikaterini Patsatsi
- 2nd Department of Dermatology and Venereology, Aristotle University School of Medicine, Thessaloniki, Greece
| | | | | | | | | | | |
Collapse
|
44
|
Trakatelli M, Siskou S, Proby C, Tiplica G, Hinrichs B, Altsitsiadis E, Kitsou A, Ferrandiz L, Aquilina S, Apap C, Ulrich M, Fiorentini C, Magnoni C, de Vries E, Flohil S, Kalokasidis K, Moreno-Ramirez D, Ruiz-de-Casas A, Majewski S, Ranki A, Pitkänen S, Saksela O, Ioannides D, Sotiriadis D, Stockfleth E. The patient journey: a report of skin cancer care across Europe. Br J Dermatol 2012; 167 Suppl 2:43-52. [DOI: 10.1111/j.1365-2133.2012.11086.x] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
45
|
Traianou A, Ulrich M, Apalla Z, De Vries E, Bakirtzi K, Kalabalikis D, Ferrandiz L, Ruiz-de-Casas A, Moreno-Ramirez D, Sotiriadis D, Ioannides D, Aquilina S, Apap C, Micallef R, Scerri L, Pitkänen S, Saksela O, Altsitsiadis E, Hinrichs B, Magnoni C, Fiorentini C, Majewski S, Ranki A, Proby C, Stockfleth E, Trakatelli M. Risk factors for actinic keratosis in eight European centres: a case-control study. Br J Dermatol 2012; 167 Suppl 2:36-42. [DOI: 10.1111/j.1365-2133.2012.11085.x] [Citation(s) in RCA: 70] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
|
46
|
de Vries E, Trakatelli M, Kalabalikis D, Ferrandiz L, Ruiz-de-Casas A, Moreno-Ramirez D, Sotiriadis D, Ioannides D, Aquilina S, Apap C, Micallef R, Scerri L, Ulrich M, Pitkänen S, Saksela O, Altsitsiadis E, Hinrichs B, Magnoni C, Fiorentini C, Majewski S, Ranki A, Stockfleth E, Proby C. Known and potential new risk factors for skin cancer in European populations: a multicentre case-control study. Br J Dermatol 2012; 167 Suppl 2:1-13. [DOI: 10.1111/j.1365-2133.2012.11081.x] [Citation(s) in RCA: 116] [Impact Index Per Article: 9.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
|
47
|
Avgerinou G, Bassukas I, Chaidemenos G, Katsampas A, Kosmadaki M, Kousoulakou H, Petridis A, Schenkel B, Sotiriadis D, Spiliopoulos T, Stavropoulos P, Toumpi E, Xaplanteris L. Budget impact analysis of ustekinumab in the management of moderate to severe psoriasis in Greece. BMC Dermatol 2012; 12:10. [PMID: 22831458 PMCID: PMC3420305 DOI: 10.1186/1471-5945-12-10] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/01/2010] [Accepted: 07/25/2012] [Indexed: 01/06/2023]
Abstract
BACKGROUND The purpose of this study was to estimate the annual and per-patient budget impact of the treatment of moderate to severe psoriasis in Greece before and after the introduction of ustekinumab. METHODS A budget impact model was constructed from a national health system perspective to depict the clinical and economic aspects of psoriasis treatment over 5 years. The model included drug acquisition, monitoring, and administration costs for both the induction and maintenance years for patients in a treatment mix with etanercept, adalimumab, infliximab, with or without ustekinumab. It also considered the resource utilization for non-responders. Greek treatment patterns and resource utilization data were derived from 110 interviews with dermatologists conducted in February 2009 and evaluated by an expert panel of 18 key opinion leaders. Officially published sources were used to derive the unit costs. Costs of adverse events and indirect costs were excluded from the analysis. Treatment response was defined as the probability of achieving a PASI 50, PASI 75, or PASI 90 response, based on published clinical trial data. RESULTS The inclusion of ustekinumab in the biological treatment mix for moderate to severe psoriasis is predicted to lead to total per-patient savings of €443 and €900 in years 1 and 5 of its introduction, respectively. The cost savings were attributed to reduced administration costs, reduced hospitalizations for non-responders, and improved efficacy. These results were mainly driven by the low number of administrations required with ustekinumab over a 5 year treatment period (22 for ustekinumab, compared with 272 for etanercept, 131 for adalimumab, and 36 for infliximab). CONCLUSIONS The inclusion of ustekinumab in the treatment of moderate to severe psoriasis in Greece is anticipated to have short- and long-term health and economic benefits, both on an annual and per-patient basis.
Collapse
Affiliation(s)
- Georgia Avgerinou
- Department of Dermatology, University of Athens, Hospital “A. Syggros”, Athens, Greece
| | - Ioannis Bassukas
- Department of Skin and Venereal Diseases, University of Ioannina, Ioannina, Greece
| | - Georgios Chaidemenos
- Department of Dermatology, Hospital for Skin and Venereal Diseases, Thessaloniki, Greece
| | - Andreas Katsampas
- Department of Dermatology, University of Athens, Hospital “A. Syggros”, Athens, Greece
| | - Marita Kosmadaki
- Department of Dermatology, University of Athens, Hospital “A. Syggros”, Athens, Greece
| | | | - Athanasios Petridis
- Department of Skin and Venereal Diseases, University of Ioannina, Ioannina, Greece
| | | | - Dimitrios Sotiriadis
- Department of Dermatology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | | | | | - Evgenia Toumpi
- Department of Dermatology and Venereology, “Attikon” General University Hospital, Athens, Greece
| | | |
Collapse
|
48
|
Abstract
Age-associated skin lesions linked to UV radiation (UVR) include actinic keratosis, non-melanoma skin cancer-such as basal cell carcinoma and squamous cell carcinoma-lentigo senilis and lentigo maligna. Their incidence is increasing worldwide, mainly due to exaggerated UV exposure and to an aging population. Early diagnosis and therapy of pre-malignant cutaneous lesions is crucial for the secondary prophylaxis of invasive and highly aggressive skin cancers. Combined efforts to increase public awareness, patient education about self-examination, prophylactic modalities, such as consistent and sufficient UV protection, and rigorous follow-up of high-risk groups are of highest importance.
Collapse
Affiliation(s)
- Fragkiski Tsatsou
- Second Department of Dermatology and Venereology; Papageorgiou Hospital; Aristotle University School of Medicine; Thessaloniki, Greece
| | | | | | | | | |
Collapse
|
49
|
Liu J, Liu J, Liu Y, Xu Y, Zhao X, Qian J, Sun B, Xing C, Kanda R, Hamada C, Nakano T, Wakabayashi K, Io H, Horikoshi S, Tomino Y, Ishimatsu N, Miyamoto T, Morimoto H, Nakamata J, Baba R, Kanegae K, Serino R, Kabashima N, Otsuji Y, Doi Y, Tamura M, Nakamata J, Morimoto H, Baba R, Ishimatsu N, Miyamoto T, Kanegae K, Serino R, Kabashima N, Otsuji Y, Doi Y, Tamura M, Kusumoto T, Fukami K, Yamagishi SI, Ueda S, Kaida Y, Hazama T, Nakayama Y, Ando R, Obara N, Okuda S, Tamura M, Matsumoto M, Miyamoto T, Kanegae K, Furuno Y, Serino R, Kabashima N, Otsuji Y, Bang-Gee H, Mazzotta L, Rosati A, Carlini A, Henriques VT, Zangiacomi Martinez E, Divino-Filho JC, Pecoits-Filho R, Cardeal Da Costa JA, Henriques VT, Henriques VT, Gama Axelsson T, Lindholm B, Carrero JJ, Heimburger O, Stenvinkel P, Qureshi AR, Akazawa M, Uno T, Kanda E, Maeda Y, Aktsiali M, Aktsiali M, Antonopoulou S, Tsiolaki K, Bakirtzi N, Patrinou A, Georgopoulou M, Liaveri P, Afentakis N, Tsirpanlis G, Hasegawa T, Nishiwaki H, Hirose M, Komukai D, Tayama H, Koiwa F, Yoshimura A, Lui SL, Lui S, Yung S, Tang C, Ng F, Lo WK, Chan TM, Koo HM, Doh FM, Yoo DE, Oh HJ, Yoo TH, Choi KH, Kang SW, Han DS, Han SH, Fernandes N, Fernandes N, Bastos MG, Gianotti Franco MR, Chaoubah A, Gloria Lima MD, Pecoits-Filho R, Divino-Filho JC, Qureshi AR, Kang S, Do J, Cho K, Park J, Yoon K, Chen JB, Cheng BC, Chen TC, Su YJ, Wu CH, Park Y, Jeon J, Tsikeloudi M, Pateinakis P, Patsatsi K, Manou E, Sotiriadis D, Tsakiris D, Teixeira L, Rodrigues A, Carvalho MJ, Cabrita A, Mendonca D, Kang S, Do J, Park J, Cho K, Yoon K, Bruschi M, Candiano G, Santucci L, Luzio S, Cannavo R, Ghiggeri GM, Verrina E, Varadarajan Y, Raju B, Cho KH, Do J, Kang S, Park JW, Yoon KW, Kim TW, Kimmel M, Braun N, Latus J, Alscher MD, Struijk D, Van Esch S, Krediet RT, Fernandes N, Van den Beukel T, Hoekstra T, Tirapani L, De Andrade Bastos K, Pecoits-Filho R, Qureshi AR, Bastos M, Dekker F, Divino-Filho JC, Yasuhisa T, Kanai H, Harada K, Kawai Y, Sugiyama H, Ito Y, Tsuruya K, Yoshida H, Maruyama H, Goto S, Nakayama M, Nakamoto H, Morinaga H, Matsuo S, Makino H, DI Gioia MC, Gallar P, Laso N, Rodriguez I, Cobo G, Oliet A, Hynostroza J, Herrero JC, Mon C, Ortiz M, Vigil A, Tomo T, Portoles J, Uta S, Uta S, Tato AM, Lopez-Sanchez P, Rivera M, Rodriguez-Pena R, Del Peso G, Ortega M, Felipe C, Tsampikaki E, Aperis G, Kaikis A, Paliouras C, Karvouniaris N, Maragaki M, Alivanis P, Kortus-Gotze B, Hoferhusch T, Hoyer J, Martino F, Kaushik M, Rodighiero MP, Creapldi C, Ronco C, Lacquaniti A, Lacquaniti A, Donato V, Fazio MR, Lucisano S, Cernaro V, Lupica R, Buemi M, Aloisi C, Uno T, Akazawa M, Kanda E, Maeda Y, Bavbek Ruzgaresen N, Secilmis S, Yilmaz H, Akcay A, Duranay M, Akalin N, Akalin N, Altiparmak MR, Trabulus S, Yalin AS, Ataman R, Serdengecti K, Schneider K, Bator B, Niko B, Braun N, Peter F, Ulmer C, Joerg L, Martin K, Dagmar B, German O, Fabian R, Juergen D, Stephan S, Dominik A, Latus J, Latus J, Ulmer C, Fritz P, Rettenmaier B, Hirschburger S, Segerer S, Biegger D, Lang T, Ott G, Kimmel M, Alscher MD, Braun N, Habib M, Korte M, Hagen M, Dor F, Betjes M, Habib M, Hagen M, Korte M, Zietse R, Dor F, Betjes M, Latus J, Latus J, Ulmer C, Fritz P, Rettenmaier B, Biegger D, Lang T, Ott G, Scharpf C, Kimmel M, Alscher MD, Braun N, Habib M, Korte M, Zietse R, Betjes M, Chang TI, Shin DH, Oh HJ, Kang SW, Han DS, Yoo TH, Han SH, Choi HY, Lee YK, Kim BS, Han SH, Yoo TH, Park HC, Lee HY, Horimoto N, Tuji K, Kitamura S, Sugiyama H, Makino H, Isshiki R, Isshiki R, Iwagami M, Tsutsumi D, Mochida Y, Ishioka K, Oka M, Maesato K, Moriya H, Ohtake T, Hidaka S, Kobayashi S, Higuchi C, Tanihata Y, Ishii M, Sugimoto H, Sato N, Kyono A, Ogawa T, Nishimura H, Otsuka K, Cho KH, Do JY, Kang S, Park JW, Yoon KW, Kim TW, Du Halgouet C, Latifa A, Anne Sophie V, Emmanuel D, Christine R, Francois V, Grzelak T, Czyzewska-Majchrzak L, Kramkowska M, Witmanowski H, Czyzewska K, Janda K, Krzanowski M, Dumnicka P, Sulowicz W, Rroji M, Seferi S, Barbullushi M, Likaj E, Petrela E, Thereska N, Cabiddu G, Dessi E, Arceri A, Laura P, Manca E, Conti M, Cao R, Pani A, Liao CT, Vega Vega O, Mendoza de la Garza A, Correa-Rotter R, Ueda A, Nagai K, Morimoto M, Hirayama A, Owada S, Tonozuka Y, Saito C, Saito C, Yamagata K, Matsuda A, Tayama Y, Ogawa T, Iwanaga M, Noiri C, Hatano M, Kiba T, Kanozawa K, Katou H, Hasegawa H, Mitarai T, Ros-Ruiz S, Ros-Ruiz S, Fuentes-Sanchez L, Jironda-Gallegos C, Gutierrez-Vilches E, Garcia-Frias P, Hernandez-Marrero D, Kang S, Lee S, Cho K, Park J, Yoon K, Do J, Lai X, Chen W, Guo Z, Braide M, Cristina V, Popa SG, Maria M, Eugen M, Martino F, DI Loreto P, DI Loreto P, Ronco C, Rroji M, Seferi S, Barbullushi M, Petrela E, Spahia N, Likaj E, Thereska N, Sanchez Macias LO, Sanchez Macias LO, Lares Castellanos KI, Hernandez Pacheco JA, Vega Vega O, Correa Rotter R, Pedro Ventura A, Olivia S, Teixeira L, Joana V, Francisco F, Maria Joao C, Antonio C, Rodrigues AS, Atas N, Erten Y, Erten Y, Onec K, Inal S, Topal S, Akyel A, Celik B, Okyay GU, Tavil Y, Zeiler M, Monteburini T, Agostinelli RM, Marinelli R, Santarelli S, Erten Y, Erten Y, Inal S, Onec K, Atas N, Okyay GU, Yaylaci C, Sahin G, Tavil Y, Guz G, Sindel S, Pinho A, Cabrita A, Malho Guedes A, Fragoso A, Carreira H, Pinto I, Bernardo I, Leao P, Janda K, Janda K, Krzanowski M, Kusnierz-Cabala B, Dumnicka P, Krasniak A, Chowaniec E, Tabor-Ciepiela B, Sulowicz W, Turkmen K, Ozbek O, Kayrak M, Samur C, Guler I, Tonbul HZ, Rusai K, Herzog R, Kratochwill K, Kuster L, Aufricht C, Meier CM, Fliser D, Schilling MK, Klingele M, Fukasawa M, Fukasawa M, Takeda M, Kamiyama M, Song YR, Kim HJ, Kim SG, Kim JK, Noh JW, Lee YK, Yoon JW, Koo JR. Peritoneal dialysis. Nephrol Dial Transplant 2012. [DOI: 10.1093/ndt/gfs243] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
50
|
|